SCHEMBL24849422

SCHEMBL24849422

CC1CCC(C2CCC(C3CCC(C4CCC(C5CCN5)CC4)C3)CC2)C1

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24938266 0.79 ALDH1A1 (0.40)
SCHEMBL8291836 0.77 L3MBTL1 (0.60) L3MBTL1
SCHEMBL24693273 0.77 L3MBTL1 (0.60) L3MBTL1
SCHEMBL13722786 0.77 L3MBTL1 (0.60) L3MBTL1
SCHEMBL6589750 0.75
SCHEMBL7553320 0.75 L3MBTL1 (0.39) L3MBTL1
SCHEMBL11401966 0.75 L3MBTL1 (0.39) L3MBTL1
SCHEMBL14230816 0.75 L3MBTL1 (0.39) L3MBTL1
SCHEMBL25152032 0.75 L3MBTL1 (0.56) L3MBTL1
SCHEMBL25151926 0.75 L3MBTL1 (0.56) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278576-A1 METHODS AND COMPOSITIONS FOR TREATING AN ANGIOTENSINOGEN- (AGT-) ASSOCIATED DISORDER ALNYLAM PHARMACEUTICALS, INC. (US) 2023-01-05 WO disclosed